Bladder Disorders Market to Exhibit a Remarkable Development of USD 22,342.48 Million by 2029, Size, Share, Trends, Rising Demand, Market Dynamics and Opportunity Analysis
LONDON, Feb. 15, 2023 /PRNewswire/ -- Data Bridge Market Research Published Latest Bladder Disorders Market Study by in-depth analysis about current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the study considers important factors such as an analysis of the market, a definition of the market, market segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. The top notch Bladder Disorders market research report provides estimations about the growth rate and the market value based on market dynamics and growth inducing factors. While preparing this market analysis report, few of the attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology. The report offers wide-ranging statistical analysis of the market's continuous developments, capacity, production, production value, cost/profit, supply/demand and import/export. The winning Bladder Disorders market report also assesses the growth rate and the market value based on market dynamics and growth inducing factors.
Global bladder disorders market is expected to grow in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 11.4% in the forecast period of 2022 to 2029 and is expected to reach USD 22,342.48 million by 2029.
Download PDF Sample of Bladder Disorders Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-bladder-disorders-market
Bladder related disorders include cystitis - inflammation of the bladder, often from an infection, Urinary incontinence - loss of bladder control, Overactive bladder - a condition in which the bladder squeezes urine out at the wrong time, Interstitial cystitis - a chronic problem that causes bladder pain and frequent, urgent urination and bladder cancer.
Different tests are performed by the doctors to diagnose the bladder disorder that includes x-rays, urine tests, and a bladder wall examination by scope called cystoscope. The treatment of the disorder depends on the cause of the problem and the treatment includes medication, surgeries (in severe cases), and non-surgical procedures.
Bladder disorders are a group of disorders that can affect human life's daily activity. Some of the most common bladder disorders are cystitis- in which the bladder is infected and causes inflammation. Urinary incontinence- loss of bladder control, interstitial cystitis- bladder pain and frequent, urgent urination, and the overactive bladder- a condition in which the bladder squeezes urine. Bladder disorders can affect the quality of life and cause other health problems. Health changes and issues, including nervous system and lifestyle factors, can cause or contribute to UI in men and women.
The Bladder Disorders Market is dominated by Firms Such as:
- Medtronic
- Laborie
- Boston Scientific Corporation
- Pfizer Inc.
- Astellas Pharma Inc.
- KYORIN Pharmaceutical Co., Ltd. (A subsidiary of KYORIN Holdings, Inc.)
- Bristol-Myers Squibb Company
- Johnson & Johnson Services, Inc.
- Axonics, Inc.
- Merck & Co., Inc.
- Viatris Inc.
- Blue Wind Medical
- Valencia Technologies
- Gaylord Chemical Company
- L.L.C.
- Coloplast Corp
- AbbVie Inc.
- Sun Pharmaceutical Industries Ltd.
- Zydus Group
- Swati Spentose
- Urovant Sciences
Market Development:
- In August 2021, Vensica Therapeutics Ltd and wMerz Therapeutics announced that they have entered into a collaboration agreement and strategic license for the delivery of botulinum neurotoxin A (Xeomin) to the bladder wall by using Vensica's innovative ultrasound-assisted delivery catheter
- In March 2022, Urovant Sciences declared positive topline results from its Phase 2a, double-blind, placebo-controlled exploratory study of URO-902. It is an investigational, novel, locally injected gene therapy product that is used in those patients with overactive bladder (OAB), who did not respond well to oral therapies. These results suggest that URO-902 could deliver new treatment for patients with overactive bladder who have been inadequately respond by oral pharmacologic therapy
- In June 2021, Taiho Pharmaceutical has developed, TAC-302 which is a medicine in Phase II development. This medication is orally works and accessible by supporting neurite outgrowth activity in cultured peripheral neurons to cure overactive bladder. The introduction of this new innovative treatment choices will increase patient uptake, which will fuel the expansion of the market
- In December 2019, Johnson & Johnson announced the acquisition with TARIS Biomedical LLC Company, a private limited biotechnology corporation that produces high-quality new and innovative drug delivery procedures for the treatment of bladder disorders, including cancer. The TAR-200 is a leading clinical-stage product of the business which used in the patented TARIS System. This silicone-based drug delivery system allows constant drug release into the bladder. The financial details of transactions are not being publicly disclosed.
Get Full PDF Research Report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-bladder-disorders-market
Opportunities
- SURGE IN NOVEL TECHNOLOGICAL ADVANCEMENTS
Chronic diseases are considered one of the major leading causes of death in developing countries worldwide. Therefore, the importance of healthcare management of chronic management is increased among public health practitioners.
Bladder disorder management now places a strong emphasis on assisting patients with a range of alternatives for self-care and a range of consultation services to educate patients about their illness state and move forward. These therapies also assist patients in getting over emotional trauma and anxiety, which may act as a counter-protective mechanism.
Rising technical breakthroughs allow healthcare organizations to explore innovative services and solutions for managing chronic bladder disorders. Since they are not required to stay in the hospital for an extended period of time, they have also decreased costs and patient volume. Furthermore, lowering hospital visits and stays makes this development convenient for older adults. Considering the favorable aspects, many organizations and businesses are developing and implementing the most recent technologies in managing chronic diseases to enhance patient outcomes.
- RISING DISEASE MANAGEMENT PROGRAMS
People with bladder-related problems typically need more medical services, such as hospital stays, doctor visits, and prescription medications. The rise in the number of people living longer with many chronic problems and increasing healthcare expenditures has encouraged better healthcare plans.
Disease management is one strategy that tries to improve care while lowering the expense of caring for the chronically ill. Programs for managing diseases aim to enhance the health of people with certain chronic disorders such as bladder disorders while lowering the demand for medical services and associated expenses for consequences that can be avoided, such as hospital stays and emergency visits. These programs also include information regarding chronic disease management services and solutions. These are becoming very popular owing to the rising prevalence of chronic diseases worldwide. Government and healthcare organizations have organized and implemented these chronic diseases with multiple disease management programs such as bladder cancer, interstitial cystitis, and overactive bladder management programs. Since disease management programs can significantly improve self-care practices and reduce hospital visits and staying periods to a more excellent extent, they receive more attention among people.
Bladder Disorders Market Scope
Type
- Cystitis
- Urinary Incontinence
- Overactive Bladder
- Interstitial Cystitis
- Bladder Cancer
Treatment type
- Surgery
- Medications
- Others
End User
- Hospital
- Clinics
- Ambulatory Surgery centers
- Others
Distribution Channel
- Direct
- Retail
Market intelligence platform will help you understand:
- Identify emerging market trends & dynamics
- Market intelligence with quality and accuracy
- Benchmark against competitors & industry
- Explore competitive strategy & market share
- Discover regional market opportunities
- Deliverable formats include PDF, PPT, Excel & Online Dashboard
View Detailed Research on Bladder Disorders Market @ https://www.databridgemarketresearch.com/reports/global-bladder-disorders-market
Bladder Disorders Market Regional Analysis/Insights
The bladder disorders market report is analyzed, and market size insights and trends are provided by country, type, treatment type, end user, and distribution channel, as referenced above
Countries covered in this market are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Turkey, Russia, Netherlands, Switzerland, Belgium and Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of the Middle East and Africa.
North America dominates the global bladder disorders market in terms of market share and revenue and will continue to flourish its dominance during the forecast period. This is due to the high prevalence of overactive bladder disorder in the region, and growing R&D investments and the launch of novel therapies are boosting the market
A comprehensive analysis will be provided covering the following points in the report:
- Executive Market Summary
- Scope of the Bladder Disorders Report
- Key Finding and Recommendations
- Growth and Investment Opportunities
- Bladder Disorders Market Value Chain/Supply Chain Analysis
- Bladder Disorders Market Attractive Investment Proposition
- Competitive landscape and SWOT Analysis
- Bladder Disorders Market Segmentation Outlook
- Regional Outlook
- Company Profiles of Key Players
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global Bladder Disorders market over the period. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Table of Contents:
- Introduction
- Market Segmentation
- Executive Summary
- Premium Insights
- Global Bladder Disorders Market: Regulations
- Market Overview
- Global Bladder Disorders Market, By Type
- Global Bladder Disorders Market, By Treatment type
- Global Bladder Disorders Market, By End User
- Global Bladder Disorders Market, By Distribution Channel
- Global Bladder Disorders Market, By Region
- Global Bladder Disorders Market: Company Landscape
- SWOT Analyses
- Company Profile
- Questionnaires
- Related Reports
Download Full Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-bladder-disorders-market
Explore DBMR Comprehensive Coverage on Healthcare Domain:
Europe Bladder Disorders Market, By Type (Cystitis, Urinary Incontinence, Overactive Bladder, Interstitial Cystitis, Bladder Cancer), Treatment Type (Surgery, Medication, Non-surgical), End User (Hospitals, Clinics, Ambulatory Surgery Centers, Others), Distribution Channel (Direct, Retail) - Industry Trends and Forecast to 2029. https://www.databridgemarketresearch.com/reports/europe-bladder-disorders-market
Asia-Pacific Bladder Disorders Market, By Type (Cystitis, Urinary Incontinence, Overactive Bladder, Interstitial Cystitis, Bladder Cancer), Treatment Type (Surgery, Medication, Non-surgical), End User (Hospitals, Clinics, Ambulatory Surgery Centers, Others), Distribution Channel (Direct, Retail) - Industry Trends and Forecast to 2029. https://www.databridgemarketresearch.com/reports/asia-pacific-bladder-disorders-market
Middle East and Africa Bladder Disorders Market, By Type (Cystitis, Urinary Incontinence, Overactive Bladder, Interstitial Cystitis, Bladder Cancer), Treatment Type (Surgery, Medication, Non-surgical), End User (Hospitals, Clinics, Ambulatory Surgery Centers, Others), Distribution Channel (Direct, Retail) - Industry Trends and Forecast to 2029. https://www.databridgemarketresearch.com/reports/middle-east-and-africa-bladder-disorders-market
North America Bladder Disorders Market, By Type (Cystitis, Urinary Incontinence, Overactive Bladder, Interstitial Cystitis, Bladder Cancer), Treatment Type (Surgery, Medication, Non-surgical), End User (Hospitals, Clinics, Ambulatory Surgery Centers, Others), Distribution Channel (Direct, Retail) - Industry Trends and Forecast to 2029. https://www.databridgemarketresearch.com/reports/north-america-bladder-disorders-market
Rise in Incidence of Chronic Diseases Drive the Demand for Bladder Disorder Market - Press Release: https://www.databridgemarketresearch.com/press-release/global-bladder-disorders-market
Overactive Bladder Treatment Market, By Pharmacotherapy (Anticholinergics, Solifenacin, Oxybutynin, Darifenacin, Fesoterodine, Tolterodine, Trospium and Others), Disease Type (Idiopathic Bladder Overactivity and Neurogenic Bladder Overactivity), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-overactive-bladder-treatment-market
Bladder Cancer Treatment Market, By Type (Urothelial Carcinoma, Squamous Cell Carcinoma, Adenocarcinoma, Others), Grade Type (Low-grade Bladder Tumor, High-grade Bladder Tumor, Others), Treatment (Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Others), Route of Administration (Oral, Parenteral, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of the Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-bladder-cancer-treatment-market
Non-Muscle Invasive Bladder Cancer Market, By Stage (Ta, Tis, T1), Treatment Class (Chemotherapy, Immunotherapy, Surgery, Radiation Therapy, Intravescial Therapy), Malignant Potential (Low-Grade Tumours, High-Grade Tumours), End-User (Hospitals, Specialized Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-non-muscle-invasive-bladder-cancer-market
Neurogenic Bladder Infections Market, By Type (Overactive, Underactive), Drug Type (Sulphonamides, Azoles and Amphotericin B, Tetracycline, Nitrofurans, Aminoglycoside Antibiotics, Cephalosporin, Quinolones, Penicillin and Combinations), Test Type (Biochemical Urinary Tract Infection, Microscopic Urinary Tract Infection, Flow Cytometric Urinary Tract Infection), Distribution Channel (Hospital Pharmacies, Gynecology and Urology Clinics, Drug Store, Retail Pharmacies, Online Drug Stores) https://www.databridgemarketresearch.com/reports/global-neurogenic-bladder-infections-market
Pediatric Bladder Treatment Market, By Type (Diurnal Incontinence, Enuresis, Others), Treatment (Urotherapy, Medication, Surgical Reconstruction, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) https://www.databridgemarketresearch.com/reports/global-paediatric-bladder-treatment-market
Bladder Cancer Therapeutics Market, By Type (Transitional Cell Bladder Cancer, Superficial Bladder Cancer, Invasive Bladder Cancer, Squamous Cell Bladder Cancer, Others), End-Users (Hospitals, Specialty Clinics, Others), Treatment (Surgery, Chemotherapy, Immunotherapy Radiation Therapy, Others), Major Tests (Cytoscopy, Biopsy, Urinalysis, Urine Cytology and Bladder Ultrasound) Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) https://www.databridgemarketresearch.com/reports/global-bladder-cancer-therapeutics-market
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. "Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve."
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
Logo: https://mma.prnewswire.com/media/1011053/Data_Bridge_Market_Research_Logo.jpg
Share this article